VenoStent

Location

VenoStent is headquartered in Houston, Texas, USA. The company operates primarily within the United States and extends its regional influence to America and Canada.

Industry and Sub-Industry

VenoStent operates within the healthcare sector, specifically focusing on the medical devices sub-industry. The company specializes in bioengineered solutions to improve outcomes of vascular surgeries.

Innovative Product: SelfWrap

VenoStent offers SelfWrap, a bioabsorbable, flexible vascular wrap designed to reduce dialysis access site failures. SelfWrap aims to address the high failure rate of dialysis access sites in the first year and is currently in the research and development phase, not yet available for sale.

Clinical Trials and FDA Designation

VenoStent is conducting a 200-subject US clinical trial for SelfWrap. The company has received Breakthrough Device Designation from the FDA and IDE Approval to commence the US trial.

Funding and Team

VenoStent has successfully completed a $16 million Series A Financing. The company leverages a team of 17 experts skilled in biomedical engineering, materials engineering, and medical 3D printing. They are part of the Y-Combinator S20 batch.

Report inaccurate information

Companies similar to VenoStent

Corveus Medical, based in Houston, TX, specializes in developing catheter-based devices for targeted nerve ablation to treat chronic heart failure, focusing on minimizing collateral tissue damage.

Q'Apel Medical specializes in developing advanced neurological catheters and systems, including the Walrus Balloon Catheter System and Hippo Advanced Aspiration System, with a significant presence in over 190 U.S. hospital systems and plans for expansion into European markets.

Cook Biotech, founded in 1995, specializes in developing advanced tissue-repair products using extracellular matrix (ECM) biomaterials derived from porcine sources.

Volumetric, based in Houston, TX, specializes in advanced 3D bioprinting technologies for creating human tissues, focusing on applications in drug development, laboratory testing, and potentially building whole human organ replacements.

InNeuroCo, founded in 2014 and part of Integer, specializes in neurovascular medical devices, aiming to transform the industry with advanced catheter solutions and a commitment to high-quality U.S.-made materials.

Trestle Biotherapeutics, based in San Diego, develops implantable therapeutic tissues to aid patients with end-stage renal disease, aiming to reduce reliance on dialysis.

TYBR Health, based in Houston, TX, is a healthcare company in the medical devices industry, focusing on developing a hydrogel to reduce internal scarring post-surgery.

inSoma Bio, based in Durham, NC, develops innovative medical devices for reconstructive plastic surgery, focusing on bio-compatible materials that enable the use of a patient's own tissue.

Organogenesis is a biotechnology company specializing in regenerative medicine products for wound care and surgical applications, with a strong focus on ethical practices and corporate social responsibility.

Second Heart Assist, based in Salt Lake City, Utah, develops innovative circulatory assist devices, including the 'Whisper' catheter-based pump and 'Freedom' wireless implant, aimed at enhancing heart and renal function.